Benchmark Maintains Buy on Quanex Building Prods, Lowers Price Target to $28
Benzinga Newsdesk 10 months ago
NewsPrice TargetAnalyst Ratings
Benchmark analyst Reuben Garner maintains Quanex Building Prods (NYSE:NX) with a Buy and lowers the price target from $30 to $28.
Benchmark analyst Reuben Garner maintains Quanex Building Prods (NYSE:NX) with a Buy and lowers the price target from $30 to $28.